Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab

Manage 2015;61:28-33. 10. Khodosovskiĭ MN, Zinchuk VV. Erythropoietin influence on the blood oxygen transport and prooxidant-antioxidant state during hepatic ischemia-reperfusion. Ross Fiziol Zh Im I M Sechenova 2014;100:592-601. 11. Kalantzi M, Kalliakmani P, Papachristou E, et al. Parameters influencing blood erythropoietin levels of renal transplant recipients during the early post-transplantation period. Transplant Proc 2014;46:3179-82. 12. Hernández-Navarrete LS, Hernández-Jiménez JD, JiménezLópez LA, Budar-Fernández LF, Méndez-López MT, MartínezMier G. Experience in kidney transplantation without blood transfusion: kidney transplantation transfusion-free in Jehovah's Witnesses. First communication in Mexico. Cir Cir 2013;81: 450-3. 13. Zabaneh R, Roger SD, El-Shahawy M, et al. Peginesatide to manage anemia in chronic kidney disease patients on peritoneal dialysis. Perit Dial Int 2015;35:481-9. 14. Bartnicki P, Kowalczyk M, Rysz J. The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection. Med Sci Monit 2013;19:599-605. 15. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos GC, Papalois A. Comparison of the attenuating capacities of erythropoietin and U-74389G concerning blood platelet counts. J Sci Achiev 2017;2:18-21.